Shionogi will pay BioVersys $6.3 million for developing BV500, BioVersys's drug candidate for non-tuberculous mycobacteria.

In its weekly update today, the US Centers for Disease Control and Prevention (CDC) reported 40 more measles cases today, ...

Relative to before the pandemic, the number of vaccinated participants fell 10% among children and 4% in adults in pandemic ...

Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...

Cambodia’s health ministry today reported a seventh human H5N1 avian flu case for the month of June, a 36-year-old woman from ...

"Do not eat recalled foods. Throw them away or return them to where you bought them,” the CDC said. “Clean your refrigerator, ...

Livestock manure around the globe is packed with antibiotic resistance genes (ARGs) that could threaten human health, ...

Recent mosquito-borne illness patterns in Europe reflect the growing geographic spread and public health impact of the ...

USAID, the world's largest funding agency for humanitarian and development, is estimated to have helped avert more than 91 ...

This week's meeting of the Advisory Committee on Immunization Practices (ACIP) Regardless of which party controlled the White ...

In the wake of this week's meeting of a newly reconstituted federal vaccine advisory board, public health, medical, and ...

Newborns are at risk for serious complications from influenza infections but are not eligible for vaccination until they are ...